Global Cancer Registry Software Market Outlook, 2017-2019 & 2026: Privacy and Data Security-Related Concerns are Restricting the Market Growth
DUBLIN, Aug. 22, 2019 /PRNewswire/ -- The "Cancer Registry Software - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.
Global Cancer Registry Software market accounted for $43.20 million in 2017 and is expected to reach $112.20 million by 2026 growing at a CAGR of 11.2% from 2017 to 2026
Some of the factors such as increase in prevalence of cancer and favorable government initiatives are impelling the market growth. However privacy and data security-related concerns are restricting the market growth. Increase in number of accountable care organizations is creating ample opportunities for the market growth.
Cancer Registry Software is a particular type of disease registry that is mainly used in order to establish and maintain a cancer incidence reporting system. The cancer registry system acts as an informational resource for the investigation of cancer and its causes. This type of registry is important as cancer is among the leading causes of death and therefore the collection of data on cancer cases from diagnosis through survivorship is beneficial in order to help identify trends and ultimately improve care for patients that are fighting cancer.
Based on type, the standalone software segment accounted for a larger share primarily due to the significant use of standalone software by government organizations & TPAs for population health management (due to its adaptability and interoperability). Also, standalone software provides practical and easy-to-use tools to store and process registry data, while standalone software customized for patient registries offers higher flexibility and features such as multiple system usage and automatic upgradation.
Based on the geography, North America dominated the market growth due to the high burden of cancer, government funding initiatives to encourage the development of cancer registries.
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Marketforecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Key Topics Covered:
1 Executive Summary
2 Preface 2.1 Abstract 2.2 Stake Holders 2.3 Research Scope 2.4 Research Methodology 2.5 Research Sources
3 Market Trend Analysis 3.1 Introduction 3.2 Drivers 3.3 Restraints 3.4 Opportunities 3.5 Threats 3.6 End User Analysis 3.7 Emerging Markets 3.8 Futuristic Market Scenario
4 Porters Five Force Analysis 4.1 Bargaining power of suppliers 4.2 Bargaining power of buyers 4.3 Threat of substitutes 4.4 Threat of new entrants 4.5 Competitive rivalry
5 Global Cancer Registry Software Market, By Type 5.1 Introduction 5.2 Integrated Software 5.3 Standalone Software
6 Global Cancer Registry Software Market, By Deployment Model 6.1 Introduction 6.2 Cloud-Based Models 6.3 On-Premise Models
7 Global Cancer Registry Software Market, By Database Type 7.1 Introduction 7.2 Commercial Databases 7.3 Public Databases
8 Global Cancer Registry Software Market, By Functionality 8.1 Introduction 8.2 Patient Care Management 8.3 Product Outcome Evaluation 8.4 Cancer Reporting to Meet State and Federal Regulations 8.5 Medical Research & Clinical Studies
9 Global Cancer Registry Software Market, By End User 9.1 Introduction 9.2 Hospitals & Medical Practices 9.3 Government Organizations & Third-Party Administrators 9.4 Pharmaceutical, Biotechnology, and Medical Device Companies 9.5 Private Payers 9.6 Research Centers 9.7 Other End Users
10 Global Cancer Registry Software Market, By Geography 10.1 Introduction 10.2 North America 10.2.1 US 10.2.2 Canada 10.2.3 Mexico 10.3 Europe 10.3.1 Germany 10.3.2 UK 10.3.3 Italy 10.3.4 France 10.3.5 Spain 10.3.6 Rest of Europe 10.4 Asia Pacific 10.4.1 Japan 10.4.2 China 10.4.3 India 10.4.4 Australia 10.4.5 New Zealand 10.4.6 South Korea 10.4.7 Rest of Asia Pacific 10.5 South America 10.5.1 Argentina 10.5.2 Brazil 10.5.3 Chile 10.5.4 Rest of South America 10.6 Middle East & Africa 10.6.1 Saudi Arabia 10.6.2 UAE 10.6.3 Qatar 10.6.4 South Africa 10.6.5 Rest of Middle East & Africa
11 Key Developments 11.1 Agreements, Partnerships, Collaborations and Joint Ventures 11.2 Acquisitions & Mergers 11.3 New Product Launch 11.4 Expansions 11.5 Other Key Strategies
12 Company Profiling 12.1 Onco, Inc. 12.2 Rocky Mountain Cancer Data Systems 12.3 Mckesson Corporation 12.4 Elekta AB (PUB) 12.5 C/Net Solutions 12.6 Electronic Registry Systems, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/e9vots
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets Laura Wood, Senior Manager [email protected]
For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/global-cancer-registry-software-market-outlook-2017-2019--2026-privacy-and-data-security-related-concerns-are-restricting-the-market-growth-300905775.html
SOURCE Research and Markets
[ Back To TMCnet.com's Homepage ]
|